title: Maternal and umbilical cord serum vitamin A, E levels and mother-to-child transmission in the non-supplemented vitamin A, E HIV-1 infected parturients with short-course zidovudine therapy.
abstract: This study was undertaken to assess the maternal and umbilical cord serum vitamin A, E levels at delivery and mother-to-child transmission in nonsupplemented vitamin A, E HIV-1 infected parturients who received short-course zidovudine therapy. Maternal and umbilical cord serum vitamin A, E levels were quantitated by high-performance liquid chromatography in 67 HIV-1 infected parturients who received short-course zidovudine therapy. Mother-to-child transmission occurred in 13.4 per cent of HIV-1 infected parturients. There were no significant differences in the mean concentrations of vitamin A, E and vitamin E/cholesterol ratio between parturients with HIV-1 infected and non-infected infants. While maternal serum vitamin E level was adequate, nearly one-third of the parturients in the study had vitamin A deficiency. In conclusion our study has shown that there was no correlation between maternal serum vitamin A, E levels and mother-to-child HIV transmission in HIV-1 infected parturients who received short-course zidovudine therapy. However, the presence of underlying vitamin A deficiency in these parturients was common, adequate and intensive maternal-infant nutritional support should be emphasized especially in developing countries as an adjunctive measure in the reduction of mother-to-child transmission of HIV as well as the reduction in maternal and perinatal morbidity.
authors.affiliation: Bamrasnaradura Hospital, Infectious Disease Control Division, Ministry of Public Health, Nonthaburi, Thailand.
authors.forename: A
authors.initials: A
authors.lastname: Wiratchai
authors.forename: W
authors.initials: W
authors.lastname: Phuapradit
authors.forename: R
authors.initials: R
authors.lastname: Sunthornkachit
authors.forename: A
authors.initials: A
authors.lastname: Chaovavanich
authors.forename: P
authors.initials: P
authors.lastname: Tantanathip
authors.forename: O
authors.initials: O
authors.lastname: Puchaiwatananon
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D005260:Female; D005312:Fetal Blood / Q000737:chemistry*; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy / Q000635:transmission*; D015497:HIV-1; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood / Q000188:drug therapy; D014801:Vitamin A / Q000032:analysis*; D014810:Vitamin E / Q000032:analysis*; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D014801:Vitamin A; D014810:Vitamin E; D015215:Zidovudine